ROSSKAMP RALF 4
4 · Dicerna Pharmaceuticals Inc · Filed Jan 10, 2020
Insider Transaction Report
Form 4
ROSSKAMP RALF
Chief Medical Officer
Transactions
- Award
Restricted Stock Units
2020-01-08+23,100→ 23,100 total→ Common Stock (23,100 underlying) - Award
Employee Stock Option (Right to Buy)
2020-01-08+85,000→ 85,000 totalExercise: $22.58Exp: 2030-01-07→ Common Stock (85,000 underlying)
Footnotes (2)
- [F1]Represents restricted stock units ("RSUs") that vest over a period of four years, with 25% of the RSUs vesting on each of the first, second, third and fourth anniversaries of January 8, 2020, subject in each case to the reporting person's continued service with the issuer through each applicable vesting date. Each RSU represents the contingent right to receive one share of the Issuer's Common Stock.
- [F2]The option vests in 48 substantially equal monthly installments, with the first installment vesting on the last day of January 2020, and the remaining shares vesting on the last day of each of the 47 months thereafter; subject in each case to the reporting person's continued service with the issuer through each applicable vesting date.